Andrew DeFilippis, MD, MSc, is a clinician with expertise in critical care cardiology, atherosclerosis, atherothrombosis and the diagnosis and treatment of acute myocardial injury, including the identification and differentiation of specific myocardial infarction subtypes. He is a translational researcher leveraging his expertise in cohort development, clinical cardiology, cardiovascular epidemiology, and acute myocardial infarction (MI) to better understand, diagnose, predict and treat the full spectrum of myocardial injury events, including specific myocardial infarction subtypes.
He is a board-certified Cardiologist and Associate Professor of Medicine in the Division of Cardiovascular Medicine at Vanderbilt University Medical Center, and an Adjunct Assistant Professor of Medicine at Johns Hopkins University and the University of Louisville.
He completed a pre-doctoral Intramural Research Training Award Program at the National Institutes of Health, medical school at Georgetown University School of Medicine, Internal Medicine Residency and a Masters of Science in Clinical Research graduate program at Emory University and Cardiovascular Fellowship at Johns Hopkins University.
Dr. DeFilippis has significant experience with the Multi-Ethnic Study of Atherosclerosis (MESA); serves on the MESA Project & Publication Committee and is the co-PI of a R-01 that is utilizing MESA to define the epidemiology of the etiologically defined subtypes of myocardial injury and infarction (1R01HL158976-01). His laboratory has been independently and continually funded by the NIH, AHA and Industry for over a decade. His work has been published in multiple peer-reviewed journals, including Annals of Internal Medicine, The Lancet, Journal of the American College of Cardiology and cited in National Guidelines.